Roche Alzheimers disease drug fails to meet primary goal Medical Dialogues Bureau11 Feb 2020 6:00 AM GMTBasel: Roche, recently announced that the gantenerumab arm of Phase II/III DIAN-TU-001 study did not meet its primary endpoint in people who have an...